Immunomedics, Inc. (IMMU) Announces Presentations at Upcoming Conferences
10/10/2013 9:32:57 AM
MORRIS PLAINS, N.J., Oct. 10, 2013 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that the Company will be making multiple presentations at 3 upcoming scientific and medical conferences.
Help employers find you! Check out all the jobs and post your resume.